Stocks and Investing Stocks and Investing
Tue, May 17, 2022

Matthew Harrison Maintained (BOLT) at Hold with Decreased Target to $5 on, May 17th, 2022


Published on 2024-10-27 21:07:05 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Bolt Biotherapeutics, Inc." (BOLT) at Hold with Decreased Target from $7 to $5 on, May 17th, 2022.

Matthew, nor any peers, have made any analyst calls on BOLT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources